Boothbay Fund Management »

Tscan Therapeutics shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Tscan Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tscan Therapeutics held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tscan Therapeutics by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $757k 772k 0.98
2025-06-30 $35k 24k 1.45
2025-03-31 $22k 16k 1.38

More positions owned by Boothbay Fund Management

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Abivax Sa Sponsored Ads (ABVX)
Revolution Medicines Call Option (RVMD)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Invesco Exch Traded Fd Tr Ii Kbw Bk Etf Call Option (KBWB)
Tesla Motors Call Option (TSLA)
Vaxcyte (PCVX)
Constellation Brands Cl A Call Option (STZ)
Apple Call Option (AAPL)
Advanced Micro Devices Call Option (AMD)
Cornerstone Strategic Value (CLM)
Liquidia Corporation Com New (LQDA)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)

View all positions for Boothbay Fund Management

Top funds holding Tscan Therapeutics

Lynx1 Capital Management
BVF
Baker Bros. Advisors
Vanguard Capital Management
Two Sigma Investments
Renaissance Technologies
Acadian Asset Management
Deer Management
Millennium Management
Jacobs Levy Equity Management
Citadel Advisors
BlackRock
Boothbay Fund Management
Marshall Wace
DC Funds

View all funds holding Tscan Therapeutics